-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price Target

Benzinga·08/21/2026 19:08:58
語音播報
JP Morgan analyst Jessica Fye reinstates Immunocore Holdings (NASDAQ:IMCR) with a Overweight and announces $50 price target.